Compare F & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | F | COR |
|---|---|---|
| Founded | 1903 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.3B | 57.4B |
| IPO Year | N/A | N/A |
| Metric | F | COR |
|---|---|---|
| Price | $13.29 | $339.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $12.08 | ★ $354.85 |
| AVG Volume (30 Days) | ★ 54.0M | 1.6M |
| Earning Date | 02-04-2026 | 02-04-2026 |
| Dividend Yield | ★ 5.63% | 0.70% |
| EPS Growth | ★ 33.19 | 5.71 |
| EPS | 1.17 | ★ 7.96 |
| Revenue | $189,588,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | N/A | $7.04 |
| Revenue Next Year | $0.76 | $6.48 |
| P/E Ratio | ★ $11.38 | $43.09 |
| Revenue Growth | 3.75 | ★ 9.31 |
| 52 Week Low | $8.44 | $223.92 |
| 52 Week High | $13.99 | $377.54 |
| Indicator | F | COR |
|---|---|---|
| Relative Strength Index (RSI) | 52.16 | 43.22 |
| Support Level | $13.49 | $339.14 |
| Resistance Level | $13.99 | $351.99 |
| Average True Range (ATR) | 0.27 | 7.41 |
| MACD | 0.00 | -1.52 |
| Stochastic Oscillator | 36.61 | 18.68 |
Ford Motor Co. manufactures automobiles under its Ford and Lincoln brands. In March 2022, the company announced that it will run its combustion engine business, Ford Blue, and its BEV business, Ford Model e, as separate businesses but still all under Ford Motor. The company has nearly 13% market share in the United States, about 10% share in the UK, and under 2% share in China including unconsolidated affiliates. Sales in the US made up about 68% of 2024 total company revenue. Ford has about 171,000 employees, including about 56,500 UAW employees, and is based in Dearborn, Michigan.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.